Ignet

Gene Information

Gene symbol: SLC45A3

Gene name: solute carrier family 45, member 3

HGNC ID: 8642

Synonyms: IPCA-6, prostein, IPCA-2, IPCA-8

Related Genes

#	Gene Symbol	Number of hits
1	CD8A	1 hits

Related Sentences

#	PMID	Sentence
1	15048720	Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
2	15048720	To determine the presence of CD8 T cells specific for naturally processed prostein-derived epitopes in healthy individuals, we developed and applied an in vitro stimulation protocol.
3	15048720	Using this protocol, we identified CD8 T cells specific for prostein in the peripheral blood of a male and a female donor.
4	15048720	Prostein-specific CD8 T cell clones specifically recognized prostein-expressing targets, including prostate tumor cell lines expressing the relevant HLA alleles.
5	15048720	The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer.
6	15048720	Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
7	15048720	To determine the presence of CD8 T cells specific for naturally processed prostein-derived epitopes in healthy individuals, we developed and applied an in vitro stimulation protocol.
8	15048720	Using this protocol, we identified CD8 T cells specific for prostein in the peripheral blood of a male and a female donor.
9	15048720	Prostein-specific CD8 T cell clones specifically recognized prostein-expressing targets, including prostate tumor cell lines expressing the relevant HLA alleles.
10	15048720	The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer.
11	15048720	Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
12	15048720	To determine the presence of CD8 T cells specific for naturally processed prostein-derived epitopes in healthy individuals, we developed and applied an in vitro stimulation protocol.
13	15048720	Using this protocol, we identified CD8 T cells specific for prostein in the peripheral blood of a male and a female donor.
14	15048720	Prostein-specific CD8 T cell clones specifically recognized prostein-expressing targets, including prostate tumor cell lines expressing the relevant HLA alleles.
15	15048720	The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer.
16	15048720	Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
17	15048720	To determine the presence of CD8 T cells specific for naturally processed prostein-derived epitopes in healthy individuals, we developed and applied an in vitro stimulation protocol.
18	15048720	Using this protocol, we identified CD8 T cells specific for prostein in the peripheral blood of a male and a female donor.
19	15048720	Prostein-specific CD8 T cell clones specifically recognized prostein-expressing targets, including prostate tumor cell lines expressing the relevant HLA alleles.
20	15048720	The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer.
21	15048720	Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate.
22	15048720	To determine the presence of CD8 T cells specific for naturally processed prostein-derived epitopes in healthy individuals, we developed and applied an in vitro stimulation protocol.
23	15048720	Using this protocol, we identified CD8 T cells specific for prostein in the peripheral blood of a male and a female donor.
24	15048720	Prostein-specific CD8 T cell clones specifically recognized prostein-expressing targets, including prostate tumor cell lines expressing the relevant HLA alleles.
25	15048720	The identification of a prostein-specific CD8 T cell repertoire supports the development of prostein in vaccination strategies against prostate cancer.